Advancing Hope: Targeted Therapies for Pediatric Brain Tumors

This insightful webinar explored the latest advancements in targeted therapies for pediatric brain tumors. This session provided an overview of recent breakthroughs in targeted therapies, which offer advantages over traditional methods like chemotherapy and radiation while minimizing side effects and improving long-term outcomes. Dr. Ira Dunkel, a leading expert in pediatric neuro-oncology, shared practical insights, including how targeted therapies work, their benefits, and guidance on accessing and discussing these options with your child’s medical team.

About the Speakers

• Dr. Ira Dunkel is a pediatric neuro-oncologist at Memorial Sloan Kettering Cancer Center, specializing in the care of children, teenagers, and young adults with brain and eye tumors. He leads clinical research focused on developing more effective therapies with fewer side effects.